Report overview
Melioidosis, also called as Whitmore's Disease, is an infectious disease caused by the bacteria Burkholderia pseudomallei. Melioidosis infection usually affects the lungs and is diagnosed by blood, urine, saliva, or skin lesion examination. Melioidosis bacteria are present in polluted water and soil, and they propagate by direct contact with the contaminated source to humans and animals.
This report aims to provide a comprehensive presentation of the global market for Melioidosis Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melioidosis Diagnostic. This report contains market size and forecasts of Melioidosis Diagnostic in global, including the following market information:
Global Melioidosis Diagnostic Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Melioidosis Diagnostic market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Bacterial culture test Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Melioidosis Diagnostic include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc, PerkinElmer Inc., InBios International, Inc., Mediven and Cell Signaling Technology, Inc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Melioidosis Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Melioidosis Diagnostic Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Melioidosis Diagnostic Market Segment Percentages, by Type, 2023 (%)
Bacterial culture test
Latex fixation test
Hemagglutination assay
Immunofluorescence
Matrix-assisted laser desorption/ionization
Direct fluorescent antibody test
Other Tests
Global Melioidosis Diagnostic Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Melioidosis Diagnostic Market Segment Percentages, by Application, 2023 (%)
Research laboratories
Hospitals
Academic institutions
Global Melioidosis Diagnostic Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Melioidosis Diagnostic Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Melioidosis Diagnostic revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Melioidosis Diagnostic revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc
PerkinElmer Inc.
InBios International, Inc.
Mediven
Cell Signaling Technology, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Melioidosis Diagnostic, market overview.
Chapter 2: Global Melioidosis Diagnostic market size in revenue.
Chapter 3: Detailed analysis of Melioidosis Diagnostic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Melioidosis Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
